US drug firm Pfizer seeks to buy UK company AstraZeneca

BMJ 2014; 348 doi: (Published 28 April 2014) Cite this as: BMJ 2014;348:g2986
  1. Andrew Jack
  1. 1Financial Times

Pfizer, the US pharmaceutical giant whose drugs include atorvastatin (Lipitor) and sildenafil (Viagra), is seeking to buy the UK drug firm AstraZeneca for £52bn (€63bn; $90bn), which would be one of the largest acquisitions in the drug sector in recent years.

The bid at £46.61 a share would signal the biggest foreign takeover of a UK based group. It follows initial approaches in January to AstraZeneca, which continues …

View Full Text

Log in

Log in through your institution


* For online subscription